4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Delusional Disorder: new trials by email Literature Review of Delusional Disorder trials Research Report on Delusional Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Research Into Antipsychotic Discontinuation and Reduction Trial Antipsychotic Reduction, Antipsychotic Maintenance - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | University College, London | 253 | 2016-03-24 | 2022-05-23 |
| D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions D-Cycloserine, Placebo, Cognitive Behavioral Therapy - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | NYU Langone Health | 58 | 2014-02-01 | 2020-03-25 |
| Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH) agomelatine - Schizophrenia, Schizoaffective Disorder | Phase 4 | Completed | Central Institute of Mental Health, Mannheim | 27 | 2013-01-01 | 2018-03-08 |
| A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis Ziprasidone - Schizophrenia, Mania | Phase 4 | Completed | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 89 | 2003-07-01 | 2021-02-21 |
Schizophrenia (4) · Schizophrenia, Paranoid (4) · Psychotic Disorders (3) · Delusions (1) · Depression (1) · Mania (1)
Mental Disorders (4) · Schizophrenia Spectrum and Other Psychotic Disorders (4) · Behavior (2) · Behavioral Symptoms (2) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Cognitive Behavioral Therapy (1) · Cycloserine (1) · Sugars (1) · agomelatine (1) · ziprasidone (1)
Central Institute of Mental Health, Mannheim (1) · NYU Langone Health (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · University College, London (1)
Brazil (1) · Germany (1) · United Kingdom (1) · United States (1)
Donald C Goff, MD (1) · Joanna Moncrieff, MBBS (1) · Mathias Zink, MD (1)